HGF and pulmonary fibrosis: In a recent issue of Stem Cell Research & Therapy, Lan et al. [1] demonstrated that transplantation of hypoxia-preconditioned MSCs exerted better therapeutic effects in a mouse model of bleomycin-induced pulmonary fibrosis and enhanced the survival rate of engrafted MSCs, partially due to upregulation of hepatocyte growth factor (HGF).